Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

DARK SECRETS: 24 | Vintage Vibes

Trump signs order aiming to slash US drug prices to match those abroad

Health policy experts support the ‘most favored nation’ plan but doubt it will withstand likely legal challenges

The Guardian - US

This serum is best-selling for a reason—it tackles everything from dryness to pigmentation, and costs less than £40

The ingredients lineup is impressive

Marie Claire

The Best Health Care Stocks to Buy

The best health care stocks offer investors a defensive hedge in an uncertain market. Here's how to find them.

Kiplinger

From analysis to the latest developments in health,
read the most diverse news in one place.

Americans would suffer most if Trump imposes pharma tariffs, sector warns

Industry says levies would hit supply chains, making medicines potentially unaffordable for some US patients

The Guardian - UK

Snake collector’s immunity quest opens path towards universal antivenom

Blood from man bitten hundreds of times by deadly snakes is used to create most broadly protective antivenom yet

The Guardian - UK

Trump hints at tariff reprieve for pharma companies that bring operations back to US

He suggests drugmakers would get ‘a lot of time’ to repatriate manufacturing before facing levies

The Guardian - UK

Doctors Pushed HIV Meds On Patients in Exchange For Lavish Meals, Trips, and Cash: Prosecutors

A pharmaceutical company that paid doctors kickbacks to push their HIV/AIDS drugs has agreed to pay a fine of more than $200 million.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

You might soon be able to get Wegovy from an online shop — here is where you need to visit

The move comes as Danish drugmaker Novo Nordisk has acted to slash the popular weight loss drug’s price

The Independent UK

AstraZeneca Moves Some Production To US Amid Tariff Threat

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.

International Business Times

Drugmaker AstraZeneca shifts more production to US amid Trump tariffs

UK and rest of Europe risk losing out to US and China unless they ramp up spending on new medicines, says CEO Pascal Soriot

The Guardian - UK

Bayer Says Legal Woes Could Force It To Pull Weedkiller

German chemicals giant Bayer said Friday it could be forced to pull its Roundup weedkiller from the market if it is not able to contain simmering legal troubles.

International Business Times

US drug firm Merck says existing Trump tariffs will cost it $200m this year

Company’s forecast does not account for threatened ‘major’ tariff that could also be levied on pharmaceutical imports

The Guardian - UK

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Company says it will create 12,000 jobs in manufacturing and R&D over next five years

The Guardian - UK

More pharmacies offer to speed prescription deliveries to customers

America’s two largest retailers want to deliver prescriptions to your doorstep, sometimes in a matter of hours

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Ministers in ‘active conversation’ with UK drug firms over potential tariffs

Government seeks ways to shield industry from possible US levies amid concern over effect on medicine supply

International Business Times

Leadership Through Kelli Rodriguez's Lens: Diversity, Communication, & Women's Empowerment

For more than 20 years, Rodriguez has played an instrumental role in launching, restructuring, and scaling global and domestic brands, cementing her reputation as an industry leader.

International Business Times

Trump Tariffs Unnerve Locals In Irish 'Pharma' Hub

Vast pharmaceutical factories pepper the green landscape in southern Ireland, but the wind turbines next to the plants outside Cork are in the eye of Donald Trump's global trade storm.

Latin Times

Novartis Plans $23 Billion US Buildout as Pharma Faces Pressure From Trump

Novartis plans a $23 billion U.S. expansion to boost drug production and counter potential import tariffs.

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

Hedge Fund Managers Are Aggressively Buying Biotech Stocks Despite Trump Hinting at Pharma Tariffs

While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce tariffs on the industry soon.

The Guardian - UK

EU drug companies warn of exodus to US as Trump threatens import tariffs

Von der Leyen urged to take ‘rapid and radical action’ as president says tariffs on pharmaceuticals coming ‘shortly’

The Guardian - UK

China, America and pay inject drama into AstraZeneca’s AGM

The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year

The Guardian - UK

Painkillers without the addiction? The new wave of non-opioid pain relief

Pharma firms are developing drugs that avoid the brain’s opioid receptors to minimise the risks of dependence and overdoses, but not all experts are convinced

The Guardian - US

Biotech group warns exit of top FDA vaccine official will ‘erode scientific standards’

Rare admonition from a sector that has largely been silent in the face of the second Trump administration

Evening Standard

Potential threat of US tariffs ‘not as stark’ as 2008 crash – Irish minister

Enterprise Minister Peter Burke said pharma tariffs could be ‘a double-edged sword’ for the US administration.

Al Jazeera

Why are users of 23andMe being urged to delete their data?

Genetic testing company’s bankruptcy proceedings could result in auction of the genetic data of 15 million users.

1 … 23 24 25 26

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.